Johns Hopkins researchers discover that an FDA-approved HIV drug may be useful in treating breast cancer metastasis

Lymphatic endothelial cells play a key role in orchestrating metastatic colonization of such organs as lymph nodes and lungs in breast cancer, Johns Hopkins researchers have found in their preclinical mouse research; they also identified FDA-approved drugs used for other indications (repurposed drugs) that could be used to inhibit or prevent metastasis. This is very… Read more »

Aleksander Popel: halting cancer’s spread

Cancer is an invasive and insidious disease. The biochemical mysteries of how it occurs, grows and spreads are areas of intense study in cancer centers and bioscience labs across the world, but engineers also are applying their particular perspectives to understanding and stopping cancer in its tracks. Aleksander Popel, PhD, a professor of biomedical engineering… Read more »

Reversing the loss of sight

A novel peptide and drug delivery system developed by a trio of Johns Hopkins researchers is close to improving vision care for millions of people who suffer from degenerative retinal diseases, such as wet age-related macular degeneration (AMD), diabetic macular edema, and diabetic retinopathy. On the eighth floor of the Johns Hopkins Wilmer Eye Institute, the… Read more »